ID

19383

Description

Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00123643

Lien

https://clinicaltrials.gov/show/NCT00123643

Mots-clés

Versions (1)
  1. 27/12/2016 27/12/2016 -
Téléchargé le

27 décembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Type 2 Diabetes Mellitus NCT00123643

Anglais

Eligibility Type 2 Diabetes Mellitus NCT00123643

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 25-75 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
type 2 diabetes mellitus for less than or equal to 10 years
Description

Non-Insulin-Dependent Diabetes Mellitus disease length

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
pre-screening hba1c > 6.5 %
Description

Glycosylated hemoglobin A

Type de données

boolean

Alias
UMLS CUI [1]
C0019018
screening 110 mg/dl < fasting plasma glucose < 240 mg/dl after 2 weeks of metformin 500 mg twice daily (b.i.d.)
Description

Plasma fasting glucose measurement | Metformin U/day Frequency

Type de données

boolean

Alias
UMLS CUI [1]
C0583513
UMLS CUI [2,1]
C0025598
UMLS CUI [2,2]
C0456683
UMLS CUI [2,3]
C0376249
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
thiazolidinedione or sulfonylurea use in previous 30 days (may undergo washout period of 30 days)
Description

Thiazolidinediones | Sulfonylurea | Washout Period

Type de données

boolean

Alias
UMLS CUI [1]
C1257987
UMLS CUI [2]
C0038766
UMLS CUI [3]
C1710661
known contraindications to use of thiazolidinedione or sulfonylurea
Description

Medical contraindication Thiazolidinediones | Medical contraindication Sulfonylurea

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1257987
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0038766
female patients must be postmenopausal, surgically sterile, or using adequate contraception
Description

Gender Contraceptive methods | Postmenopausal state | Female Sterilization

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C0232970
UMLS CUI [3]
C0015787
uncontrolled hyperlipidemia according to american heart association (aha) guidelines
Description

Hyperlipidemia Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020473
UMLS CUI [1,2]
C0205318
subcutaneous insulin use
Description

Subcutaneous injection of insulin

Type de données

boolean

Alias
UMLS CUI [1]
C0586328
elevated liver enzymes (2.5 times the upper limit of the reference range)
Description

Elevated liver enzymes

Type de données

boolean

Alias
UMLS CUI [1]
C0235996
serum creatinine >160 mmol/l
Description

Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
anemia (hb <11 g/dl for men or <10 g/dl for women)
Description

Anemia | Hemoglobin measurement | Gender

Type de données

boolean

Alias
UMLS CUI [1]
C0002871
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0079399
body mass index (bmi) <22 or >42 kg/m2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
history of ketoacidosis
Description

Ketoacidosis

Type de données

boolean

Alias
UMLS CUI [1]
C0220982
angina/new york health academy class iii/iv cardiac insufficiency
Description

Angina Pectoris | Heart failure New York Heart Association Classification

Type de données

boolean

Alias
UMLS CUI [1]
C0002962
UMLS CUI [2,1]
C0018801
UMLS CUI [2,2]
C1275491
electrocardiographic evidence of marked left ventricular hypertrophy
Description

Electrocardiogram: left ventricle hypertrophy Marked Evidence of

Type de données

boolean

Alias
UMLS CUI [1,1]
C0232306
UMLS CUI [1,2]
C1706089
UMLS CUI [1,3]
C0332120
uncontrolled hypertension according to aha guidelines
Description

Uncontrolled hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C1868885
hemoglobinopathy
Description

Hemoglobinopathy

Type de données

boolean

Alias
UMLS CUI [1]
C0019045
Retour au début de la page

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00123643

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 25-75 years
boolean
C0001779 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetes mellitus for less than or equal to 10 years
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Glycosylated hemoglobin A
Item
pre-screening hba1c > 6.5 %
boolean
C0019018 (UMLS CUI [1])
Plasma fasting glucose measurement | Metformin U/day Frequency
Item
screening 110 mg/dl < fasting plasma glucose < 240 mg/dl after 2 weeks of metformin 500 mg twice daily (b.i.d.)
boolean
C0583513 (UMLS CUI [1])
C0025598 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0376249 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Thiazolidinediones | Sulfonylurea | Washout Period
Item
thiazolidinedione or sulfonylurea use in previous 30 days (may undergo washout period of 30 days)
boolean
C1257987 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
C1710661 (UMLS CUI [3])
Medical contraindication Thiazolidinediones | Medical contraindication Sulfonylurea
Item
known contraindications to use of thiazolidinedione or sulfonylurea
boolean
C1301624 (UMLS CUI [1,1])
C1257987 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0038766 (UMLS CUI [2,2])
Gender Contraceptive methods | Postmenopausal state | Female Sterilization
Item
female patients must be postmenopausal, surgically sterile, or using adequate contraception
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0232970 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
Hyperlipidemia Uncontrolled
Item
uncontrolled hyperlipidemia according to american heart association (aha) guidelines
boolean
C0020473 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Subcutaneous injection of insulin
Item
subcutaneous insulin use
boolean
C0586328 (UMLS CUI [1])
Elevated liver enzymes
Item
elevated liver enzymes (2.5 times the upper limit of the reference range)
boolean
C0235996 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine >160 mmol/l
boolean
C0201976 (UMLS CUI [1])
Anemia | Hemoglobin measurement | Gender
Item
anemia (hb <11 g/dl for men or <10 g/dl for women)
boolean
C0002871 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Body mass index
Item
body mass index (bmi) <22 or >42 kg/m2
boolean
C1305855 (UMLS CUI [1])
Ketoacidosis
Item
history of ketoacidosis
boolean
C0220982 (UMLS CUI [1])
Angina Pectoris | Heart failure New York Heart Association Classification
Item
angina/new york health academy class iii/iv cardiac insufficiency
boolean
C0002962 (UMLS CUI [1])
C0018801 (UMLS CUI [2,1])
C1275491 (UMLS CUI [2,2])
Electrocardiogram: left ventricle hypertrophy Marked Evidence of
Item
electrocardiographic evidence of marked left ventricular hypertrophy
boolean
C0232306 (UMLS CUI [1,1])
C1706089 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
Uncontrolled hypertension
Item
uncontrolled hypertension according to aha guidelines
boolean
C1868885 (UMLS CUI [1])
Hemoglobinopathy
Item
hemoglobinopathy
boolean
C0019045 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial